Soleno Therapeutics Announces Presentations at the 2022 European Congress of Endocrinology
REDWOOD CITY, Calif., May 19, 2022 -- Soleno Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced... | May 19, 2022